GALEOTTI, NICOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.005
NA - Nord America 10.749
AS - Asia 1.349
AF - Africa 33
SA - Sud America 8
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 32.154
Salva come PNG Salva come JPEG
Nazione #
PL - Polonia 15.942
US - Stati Uniti d'America 10.704
IE - Irlanda 936
SE - Svezia 813
IT - Italia 798
HK - Hong Kong 459
UA - Ucraina 448
DE - Germania 395
VN - Vietnam 317
CN - Cina 245
GB - Regno Unito 236
FI - Finlandia 211
KR - Corea 98
TR - Turchia 74
JO - Giordania 65
RU - Federazione Russa 43
CA - Canada 41
FR - Francia 41
RO - Romania 36
SC - Seychelles 31
CH - Svizzera 27
NL - Olanda 26
BE - Belgio 24
SG - Singapore 24
IN - India 23
JP - Giappone 23
ES - Italia 12
IR - Iran 7
NZ - Nuova Zelanda 5
TW - Taiwan 5
MX - Messico 4
EU - Europa 3
RS - Serbia 3
AR - Argentina 2
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
ID - Indonesia 2
LT - Lituania 2
PE - Perù 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
DK - Danimarca 1
IL - Israele 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MU - Mauritius 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RE - Reunion 1
Totale 32.154
Salva come PNG Salva come JPEG
Città #
Warsaw 15.937
Fairfield 1.678
Ashburn 1.050
Dublin 930
Chandler 791
Woodbridge 785
Seattle 722
Cambridge 689
Jacksonville 685
Houston 605
Wilmington 597
Altamura 316
Lawrence 281
Dong Ket 279
Hong Kong 269
Ann Arbor 266
Princeton 244
Boardman 172
Beijing 159
Boston 155
San Diego 139
Medford 100
Phoenix 97
Falls Church 80
Seongnam 73
Izmir 67
Florence 64
Milan 43
Shanghai 41
Washington 40
Norwalk 39
Buffalo 35
Timisoara 33
Moscow 30
Auburn Hills 29
Hillsboro 29
Dearborn 28
Bern 26
Frankfurt Am Main 25
Andover 24
Brussels 24
New York 23
Verona 23
Tokyo 18
Los Angeles 17
Toronto 17
London 16
Guangzhou 14
Tappahannock 10
Barcelona 9
Bremen 9
Mcallen 8
Ottawa 8
Pune 8
Rome 8
Saint Louis 8
Nanjing 7
Naples 7
Philadelphia 7
Redmond 7
Seoul 7
Singapore 7
Bologna 6
Detroit 6
Helsinki 6
Prescot 6
Redwood City 6
Shijiazhuang 6
Bolton 5
Bolzano 5
Frankfurt am Main 5
Laurel 5
Menlo Park 5
Moncalieri 5
Munich 5
Naaldwijk 5
Nürnberg 5
Prato 5
Sesto Fiorentino 5
Amsterdam 4
Bari 4
Bengaluru 4
Chennai 4
Easton 4
Livorno 4
Montreal 4
Old Bridge 4
Palermo 4
Salerno 4
San Jose 4
Scarborough 4
Auckland 3
Belgrade 3
Brooklyn 3
Edinburgh 3
Fano 3
Kilburn 3
Lappeenranta 3
Lowton 3
Manchester 3
Totale 28.080
Salva come PNG Salva come JPEG
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 431
M1 receptor activation is a requirement for arecoline analgesia. 315
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 305
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 280
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 264
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 258
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 254
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 251
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 250
ERK1/2 phosphorylation is involved in the antidepressant-like action of 2,5-diphenyl-3-(4-fluorophenylseleno)-selenophene in mice 249
Antidepressant phenotype by inhibiting the phospholipase Cβ(1)--protein kinase Cγ pathway in the forced swim test. 246
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 246
Contribution of G inhibitory protein alpha subunits in paradoxical hyperalgesia elicited by exceedingly low doses of morphine in mice. 245
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 243
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 241
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 238
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 238
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 238
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 237
Brain histamine is crucial for selective serotonin reuptake inhibitors behavioral and neurochemical effects 235
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 234
The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. 233
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 232
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 232
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 232
LOCAL ANAESTHETIC ACTIVITY OF MONOTERPENES AND PHENYLPROPANES OF ESSENTIAL OILS 231
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 231
Prochlorperazine induces central antinociception mediated by the muscarinic system. 231
Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation. 231
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 230
Role of intracellular calcium in acute thermal pain perception 230
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 230
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 230
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 229
Memory facilitation with atropine: a paradoxical effect 229
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 229
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 227
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 227
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 227
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 226
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 226
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 224
Endogenous morphine modulates acute thermonociception in mice. 224
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 224
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 223
Influence of potassium channel modulators on cognitive processes in mice 223
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 222
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 222
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 220
Central neuronal functions of histamine H4 receptors 220
Effect of K+ channel modulation on mouse feeding behaviour 219
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 219
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 219
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. 219
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 218
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 218
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 216
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 216
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 216
Pharmacological in vivo test to evaluate the bioavailability of some St. John’s wort innovative oral preparations 216
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 216
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 216
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 215
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 215
Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. 215
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 215
In vitro characterization of a novel, potent and selective M3 antagonist 214
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 213
Ryanodine receptors are involved in muscarinic antinociception in mice. 213
Antihyperalgesic activity of verbascoside in two models of neuropathic pain. 213
Signaling pathway of morphine induced acute thermal hyperalgesia in mice. 210
Antihyperalgesic activity of verbascoside in the chronic constriction injury of the sciatic nerve (CCI) and intra-articular injection of sodium monoiodoacetate (MIA) models of neuropatic pain 210
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 209
Enlarging the NSAIDs family: ether, ester and acid derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents. 209
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 208
St. John's wort relieves pain in an animal model of migraine. 207
Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. 207
Caffeine induces central cholinergic analgesia. 206
Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal nociception. 204
INDOMETHACIN, CAFFEINE AND PROCHLORPERAZINE ALONE AND COMBINED REVERT HYPERALGESIA IN VIVO MODELS OF MIGRAINE 204
ANTINOCICEPTIVE EFFECT OF R-(+)-HYOSCYAMMINE ON THE CONJUNCTIVAL REFLEX TEST IN RABBITS 203
H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. 201
Neurotransmitter role of endogenous morphine in CNS. 200
Targeting JNK to prevent antiretroviral neuropathy 200
ANTINOCICEPTION INDUCED BY SM32 DEPENDS ON CENTRAL CHOLINERGIC MECHANISM 199
Local anaesthetic activity of beta-caryophyllene. 199
Pharmacological in vivo test to evaluate the bioavailability of some St. John's wort innovative oral preparations 199
Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. 197
PKC-Dependent Signaling Pathways within PAG and Thalamus Contribute to the Nitric Oxide-Induced Nociceptive Behavior 197
Pleiotropic effect of histamine H4 receptor modulation in the central nervous system 196
Reversal of NO-induced nociceptive hypersensitivity by St. John’s wort and hypericin: NF-κB, CREB and STAT1 as molecular targets 196
St. John's Wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes 196
ACETYL-L-CARNITINE INDUCES MUSCARINIC ANTINOCICEPTION IN MICE AND RATS 195
Design, synthesis and preliminary pharmacological evaluation of 1,4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic drugs. 193
LOCAL ANAESTHETIC AVTIVITY OF ESSENTIAL OIL OF LAVANDULA ANGUSTIFOLIA 193
Inhibition of the PKCγ-ε Pathway Relieves from Meningeal Nociception in an Animal Model: An Innovative Perspective for Migraine Therapy? 193
Are the contractions of rabbit peripheral lung, guinea-pig gall-bladder and guinea-pig uterus mediated by identical receptor subtype? 193
Alpha-2 agonits induce amnesia through activation of the Gi-protein signalling pathway. 192
ANTIAMNESIC EFFECT OF THE TWO NOVEL K-OPIOID AGONISTS, VA-100 AND VA-101, IN THE MOUSE PASSIVE AVOIDANCE TEST 192
Memory facilitation and stimulation of endogenous nerve growth factor synthesis by the ACh releaser PG9 189
Totale 22.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.484 0 0 0 0 0 0 0 0 0 537 1.159 788
2019/20207.455 582 971 319 572 898 724 614 932 575 437 766 65
2020/20215.296 440 592 184 656 279 628 301 447 397 770 131 471
2021/20221.848 48 176 180 58 87 99 74 130 98 129 330 439
2022/20234.004 392 785 187 244 334 717 528 227 369 18 141 62
2023/20241.807 85 190 322 110 137 250 71 537 48 57 0 0
Totale 32.492